We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (236)
- COVID-19 (55)
- Compliance and enforcement (48)
- Vaping hub (33)
- Import and export (21)
- Medicinal cannabis hub (19)
- Safety monitoring and information (13)
- Scheduling (national classification system) (13)
- Manufacturing (11)
- Weight loss products (8)
- Legislation (7)
- Labelling and packaging (4)
- Shortages and supply disruptions (4)
- Cosmetics (3)
- Prescription opioids hub (2)
- Unique Device Identification (UDI) hub (2)
- Committees and advisory bodies (1)
- Fees and payments (1)
- Sunscreens (1)
Search
530 result(s) found, displaying 476 to 500
-
Media releasesInformation about influenza vaccines for use in 2018
-
Media releasesIn reference to the ABC’s Fact Check article “Will the move to make codeine prescription-only save a100 lives a year” the Therapeutic Goods Administration (TGA) would like to clarify:
-
Media releasesThe medicines’ regulator is not proposing and will not be stopping GPs from prescribing high dose opioids
-
Media releasesThe TGA has issued a discussion paper on the use and misuse of prescription strong opioids, such as oxycodone, and whether there is a need for specific regulatory responses
-
Media releasesInformation about the TGA operations over the 2015/16 Christmas/New Year period
-
Media releasesStage two report for the Review of Medicines and Medical Devices has been released
-
Media releasesThe Therapeutic Goods Administration has published an interim decision on a proposal to up-schedule codeine
-
Media releasesThe TGA has imposed two new conditions on the inclusion of the SynchroMed II Programmable Pump in the Australian Register of Therapeutic Goods
-
Media releasesFrom 1 July 2015 commercial IVD medical devices will be monitored under the Regulatory Compliance Framework
-
Media releasesFrom 1 July 2015, new guidance and forms for Additional trade names and Extensions of Indications applications will be available
-
Media releasesBetween 24 May and 16 June, the ACBPS, TGA and APVMA took part in an international crackdown on fake and illegal medicines
-
Media releases
-
Media releasesThe TGA is aware of regulatory action undertaken by the US Food and Drug Administration (FDA) in relation to the Maquet manufacturing facility in Hudson, New Hampshire, USA
-
Media releasesNext Tuesday we will be launching the new TGA Business Services site.
-
Media releases
-
-
Compliance undertakingsUndertaking to the Secretary of the Australian Government Department of Health given for the purposes of section 42YL of the Act
-
Media releasesThe TGA and NPS Medicinewise have worked together to create two interactive online learning modules
-
Media releasesThe Australian and New Zealand Governments have agreed to cease efforts to establish a joint therapeutic products regulator, the Australia New Zealand Therapeutic Products Agency (ANZTPA).
-
-
Media releasesThe annual report contains information about hip, knee and shoulder orthopaedic implants that are having higher-than-expected rates of revision.
-
Media releases
-
-
-
Media releasesNews about information to assist importers, manufacturers and suppliers to determine whether their products are food or therapeutic goods